Your browser doesn't support javascript.
loading
Locally invasive recurrence or metastasis of pheochromocytoma into the liver?-clinicopathological challenges.
Tang, Sarah S; Lee, James W K; Wijerethne, Sujith; Iyer, Shridhar Ganpathi; Hue, Susan; En, Nga Min; Parameswaran, Rajeev.
Afiliação
  • Tang SS; Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Lee JWK; Division of Endocrine Surgery, University Surgical Cluster, National University Health System, National University Hospital, Singapore, Singapore.
  • Wijerethne S; Division of Endocrine Surgery, University Surgical Cluster, National University Health System, National University Hospital, Singapore, Singapore.
  • Iyer SG; Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Hue S; Division of General Surgery (Hepatobiliary & Pancreatic Surgery), Department of Surgery, National University Hospital, Singapore, Singapore.
  • En NM; Department of Pathology, National University Hospital, Singapore, Singapore.
  • Parameswaran R; Department of Pathology, National University Hospital, Singapore, Singapore.
World J Surg Oncol ; 20(1): 360, 2022 Nov 11.
Article em En | MEDLINE | ID: mdl-36368995
Pheochromocytomas (PCC) are rare and functional neuroendocrine tumors developing from adrenal chromaffin cells. Predicting malignant behavior especially in the absence of metastasis can be quite challenging even in the era of improved understanding of the molecular mechanisms involved in PCCs. Currently, two histopathological grading systems Pheochromocytoma of the Adrenal Gland Scaled Score (PASS) and Grading of Adrenal Pheochromocytoma and Paraganglioma (GAPP) score are used in clinical practice, but these are subject to significant interobserver variability. Some of the most useful clinical factors associated with malignancy are large size ([4-5 cm), and genetic features such as presence of SDHB germline mutations. Local invasion is uncommon in PCC and metastasis seen in 10 to 17% but higher in germline mutations and when this occurs management can be challenging. Here, we report on a case with challenges faced by the pathologist and clinicians alike in diagnosis and management of PCC recurrence.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Paraganglioma / Feocromocitoma / Neoplasias das Glândulas Suprarrenais Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Revista: World J Surg Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Singapura

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Paraganglioma / Feocromocitoma / Neoplasias das Glândulas Suprarrenais Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Revista: World J Surg Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Singapura